logo
One in five women in WHO Southeast Asia region covered under health insurance, study estimates

One in five women in WHO Southeast Asia region covered under health insurance, study estimates

The Hindu16 hours ago
About one in every five women in the WHO Southeast Asia Region, including India, are covered under a health insurance, a study published in The Lancet Regional Health Southeast Asia has estimated.
One in eight women in the region — defined by the World Health Organization (WHO) — were enrolled in social security schemes. At the same time, only one in thirteen had privately purchased or commercial insurance, the analysis reveals.
The 'WHO Southeast Asia Region' includes India, among other countries such as Bangladesh, Myanmar and Indonesia. Researchers from Health Systems Transformation Platform and Population Council Consulting Private Limited, New Delhi, also found that one in four men in the region had health insurance coverage, with the highest prevalence seen in Indonesia at over 56 per cent and lowest in Myanmar at about 1.5 per cent.
In India, the prevalence of health insurance uptake was 53 per cent among women and 56 per cent among men, the team found. The highest levels of health insurance coverage for women and men in the region were found in Indonesia, while the lowest levels were reported in Bangladesh and Myanmar, respectively.
Addressing limited health insurance coverage
Equity in accessing quality healthcare without experiencing financial hardship is key to achieving Universal Health Coverage (UHC) — one of the core aims of the United Nations' Sustainable Development Goals — especially in low- and middle-income countries in the WHO Southeast Asia Region, the authors of the study said. They added that healthcare demands and costs are expected to rise in the region as populations age. However, high out-of-pocket expenditures remain a barrier despite health insurance programmes in the region, they said.
The study analysed socioeconomic and demographic factors to estimate coverage under any health insurance, using data from Demographic and Health Surveys (2015-2022) conducted in the WHO Southeast Asia Region every five years.
"Approximately one in five women in the region were covered by any form of health insurance," the authors wrote. "In contrast, one in four men in the region had any health insurance coverage, with the highest prevalence observed in Indonesia (56.6 per cent) and the lowest in Myanmar (1.4 per cent)," they wrote.
Older age, higher education levels, and higher exposure to media were found to positively influence insurance coverage for both men and women in India, Indonesia, Nepal, Bangladesh and Myanmar.
Beyond individual factors
Further, beyond individual factors, contextual ones such as government commitment, design and implementation of insurance schemes and economic conditions are crucial in determining health insurance coverage, the authors said.
Traditional beliefs and a lack of trust in formal financial systems can hinder insurance adoption among South Asian communities, they added.
Evidence suggests that in rural areas of India, Nepal and Bangladesh, people relied on community-based informal support systems over formal insurance, reflecting cultural preferences that affect enrolment rates, the team said.
Bridging the health coverage gap
The study's findings, therefore, highlight that country-specific contexts need to be addressed to effectively expand health insurance coverage, the authors said.
They suggested policies should prioritise building sustainable health financing systems, making healthcare infrastructures more resilient, and fostering widespread awareness in the community about the benefits of health insurance.
Further, strategies aimed at resolving socioeconomic disparities and for the underinsured populations are vital in advancing equitable health insurance access and accelerating progress towards UHC, the team said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

14 million children did not receive a single vaccine in 2024, says UN
14 million children did not receive a single vaccine in 2024, says UN

Business Standard

time2 hours ago

  • Business Standard

14 million children did not receive a single vaccine in 2024, says UN

More than 14 million children did not receive a single vaccine last year about the same number as the year before according to UN health officials. Nine countries accounted for more than half of those unprotected children. In their annual estimate of global vaccine coverage, released Tuesday, the World Health Organization and UNICEF said about 89 per cent of children under one year old got a first dose of the diphtheria, tetanus and whooping cough vaccine in 2024, the same as in 2023. About 85 per cent completed the three-dose series, up from 84 per cent in 2023. Officials acknowledged, however, that the collapse of international aid this year will make it more difficult to reduce the number of unprotected children. In January, US President Trump withdrew the country from the WHO, froze nearly all humanitarian aid and later moved to close the US AID Agency. And last month, Health Secretary Robert F. Kennedy Jr. said it was pulling the billions of dollars the US had previously pledged to the vaccines alliance Gavi, saying the group had "ignored the science". Kennedy, a longtime vaccine skeptic, has previously raised questions the diphtheria, tetanus and whooping cough vaccine which has proven to be safe and effective after years of study and real-world use. Vaccines prevent 3.5 million to 5 million deaths a year, according to UN estimates. "Drastic cuts in aid, coupled with misinformation about the safety of vaccines, threaten to unwind decades of progress," said WHO Director-General Tedros Adhanom Ghebreyesus. UN experts said that access to vaccines remained "deeply unequal" and that conflict and humanitarian crises quickly unraveled progress; Sudan had the lowest reported coverage against diphtheria, tetanus and whooping cough. The data showed that nine countries accounted for 52 per cent of all children who missed out on immunisations entirely: Nigeria, India, Sudan, Congo, Ethiopia, Indonesia, Yemen, Afghanistan and Angola. WHO and UNICEF said that coverage against measles rose slightly, with 76 per cent of children worldwide receiving both vaccine doses. But experts say measles vaccine rates need to reach 95 per cent to prevent outbreaks of the extremely contagious disease. WHO noted that 60 countries reported big measles outbreaks last year. The US is now having its worst measles outbreak in more than three decades, while the disease has also surged across Europe, with 1,25,000 cases in 2024 twice as many as the previous year, according to WHO. Last week, British authorities reported a child died of measles in a Liverpool hospital. Health officials said that despite years of efforts to raise awareness, only about 84 per cent of children in the UK are protected. "It is hugely concerning, but not at all surprising, that we are continuing to see outbreaks of measles," said Helen Bradford, a professor of children's health at University College London. "The only way to stop measles spreading is with vaccination," she said in a statement. "It is never too late to be vaccinated even as an adult. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Int'l AIDS forum kicks off in Rwanda's capital
Int'l AIDS forum kicks off in Rwanda's capital

United News of India

time7 hours ago

  • United News of India

Int'l AIDS forum kicks off in Rwanda's capital

Kigali, July 14 (UNI) The 13th International AIDS Society (IAS) Conference on HIV Science officially opened Monday in the Rwandan capital of Kigali, with a strong call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global funding challenges. The event, themed "Breakthroughs amid Crisis: the Future of HIV Innovation," has convened about 4,000 participants, including global leaders, researchers, scientists, and civil society members. Speaking at the conference, Rwandan Minister of Health Sabin Nsanzimana said that Rwanda's experience in the HIV response over the past few decades demonstrates what is possible when countries prioritize people-centered approaches and invest in strategic partnerships. "We have better tools for prevention and treatment. We have better ways to engage our communities to fight stigma and discrimination, and better integration within our systems. This means we can not only achieve HIV control, but we also need to strengthen our health systems," he added. IAS President Beatriz Grinsztein underlined new World Health Organization (WHO) guidelines, groundbreaking licensing agreements, and promising research as signs that long-acting HIV prevention and treatment options are becoming more feasible for widespread use. "Our next challenge is clear: leaders must commit the funding and resources needed to integrate these scientific advances into health systems quickly and equitably so that people everywhere can benefit from these life-changing options," Grinsztejn emphasized. At the event, the WHO issued a statement announcing new guidelines that recommend using injectable lenacapavir twice a year as an additional pre-exposure prophylaxis option for HIV prevention -- a landmark policy action that could help reshape the global HIV response. "While an HIV vaccine remains elusive, lenacapavir is the next best thing: a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk," WHO Director-General Tedros Adhanom Ghebreyesus is quoted as saying in the statement. The IAS Conference on HIV Science is recognized as the world's most influential meeting on HIV research and its applications. Its 2025 edition, which runs until Thursday, features hundreds of sessions and presentations focused on translating scientific breakthroughs into real-world impact, with a particular emphasis on solutions for regions and populations most affected by HIV. UNI XINHUA GNK

WHO recommends Gilead's twice-yearly injection for HIV prevention
WHO recommends Gilead's twice-yearly injection for HIV prevention

Economic Times

time7 hours ago

  • Economic Times

WHO recommends Gilead's twice-yearly injection for HIV prevention

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection. The recommendation, issued at the International AIDS Conference in Kigali, Rwanda, comes nearly a month after the U.S. health regulator approved the drug, giving patients new hope of interrupting virus transmission. The twice-yearly injectable offers a long-acting alternative to daily oral pills and other shorter-acting options, reshaping the response to the disease especially among those who face challenges with daily adherence, stigma, or access to health care. "While an HIV vaccine remains elusive, lenacapavir is the next best thing," said Tedros Adhanom Ghebreyesus, WHO Director-General. The WHO's recommendations come at a critical moment as HIV prevention efforts stagnate with 1.3 million new HIV infections occurring in 2024 as funding challenges, stigma around the disease persist. These infections disproportionately impact populations such as sex workers, men who have sex with men, transgender people, people who inject drugs, people in prisons, and children and has also recommended a public health approach to HIV testing using HIV rapid tests that would remove a major access barrier by eliminating complex and costly part of a class of drugs known as capsid inhibitors, proved nearly 100% effective at preventing HIV in large trials last year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store